Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

John A. Charlson MD

John A. Charlson MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center
Member of the Center For Patient Care and Outcomes Research (PCOR)


Publications

  • Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 Dec 20;34(36):4398-4404 PMID: 27998232 PMCID: PMC5455308 12/22/2016
  • Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall. (Saeed H, King DM, Johnstone CA, Charlson JA, Hackbarth DA, Neilson JC, Bedi M) Int J Surg Oncol 2016;2016:5963167 PMID: 27803813 PMCID: PMC5075633 11/03/2016
  • Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. (Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM) J Natl Compr Canc Netw 2016 Jul;14(7):875-80 PMID: 27407128 07/14/2016
  • Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? (Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK) J Surg Oncol 2016 Jun;113(7):823-7 PMID: 27060344 04/10/2016
  • Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. (Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK) Int J Clin Oncol 2016 Jun;21(3):602-8 PMID: 26646222 12/10/2015
  • Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:531 PMID: 26413437 PMCID: PMC4577495 09/29/2015
  • Biopsies in the Community Lead to Postoperative Complications in Soft Tissue Sarcomas. (Bedi M, King DM, Hackbarth DA, Charlson JA, Baynes K, Neilson JC) Orthopedics 2015 Sep;38(9):e753-9 PMID: 26375531 09/17/2015
  • Retroperitoneal solitary fibrous tumor: surgery as first line therapy. (Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK) Clin Sarcoma Res 2015;5:19 PMID: 26322223 PMCID: PMC4551387 09/01/2015
  • Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. (Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK) Eur J Surg Oncol 2015 Oct;41(10):1386-92 PMID: 26251340 08/08/2015
  • Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. (Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ) J Community Support Oncol 2015 May;13(5):195-201 PMID: 26029936 PMCID: PMC4511377 06/02/2015
  • The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. (Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE) J Natl Cancer Inst 2015 Aug;107(8) PMID: 25971298 PMCID: PMC4580559 05/15/2015
  • Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:54 PMID: 25674506 PMCID: PMC4320689 02/13/2015
  • Medicare Part D low-income subsidy and disparities in breast cancer treatment. (Neuner J, Smith E, Charlson JA, Pezzin L, Laud P) J Clin Oncol 2014 Oct 20;32(30_suppl):2 PMID: 28141273 10/20/2014
  • The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. (Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D) Am J Clin Oncol 2015 Apr;38(2):184-8 PMID: 23563214 04/09/2013
  • Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 PMID: 23497372 PMCID: PMC3621722 03/19/2013
  • Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. (Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D) Am J Clin Oncol 2014 Jun;37(3):272-7 PMID: 23275272 01/01/2013
  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 04/07/2012
  • Adamantinoma with plasmacytoid features: expanding the spectrum of a diagnostically challenging entity. (Walters MP, Baynes K, Carrera GF, King DM, Wang D, Charlson J, Zambrano E) Ann Diagn Pathol 2011 Oct;15(5):347-54 PMID: 20952283 10/19/2010
  • Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 PMID: 20846560 09/18/2010
  • Last update: 09/01/2017
    jenkins-FCD Prod-130 96200611f8481f0aa4f84230b11dd74d063847a3